Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study-Reference-Cited by-同舟云学术

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study

Published:2012-02-07 Issue:5 Volume:110 Page:699-708
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Huber Severine,Schwentner Christian,Taeger Dirk,Pesch Beate,Nasterlack Michael,Leng Gabriele,Mayer Thomas,Gawrych Katarzyna,Bonberg Nadin,Pelster Martin,Johnen Georg,Bontrup Heike,Wellhäußer Harald,Bierfreund Hans-Georg,Wiens Christian,Bayer Christian,Eberle Friedhelm,Scheuermann Bernd,Kluckert Mattias,Feil Gerhard,Brüning Thomas,Stenzl Arnulf,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10883.x/fullpdf

Reference33 articles.

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland. 3.aktualisierte Ausgabe, Saarbrücken 2002

2. Occupation and risk of cancer of the lower urinary tract among men. A case-control study;Claude;Int J Cancer,1988

3. Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Mulitcenter Urothelial and Renal Cancer Study;Pesch;Int J Epidemiol,2000

4. Blasengeschwülste bei Fuchsinarbeitern;Rehn;Arch Klin Clin,1895

5. Risk factors of BC in a cohort exposed to aromatic amines;Schulte;Cancer,1986

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off the fog to find the optimal choice: Research advances in biomarkers for early diagnosis and recurrence monitoring of bladder cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

2. Urinary Biomarkers: Current Status and Future Opportunities;Comprehensive Diagnostic Approach to Bladder Cancer;2021

3. An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells;Journal of Clinical Laboratory Analysis;2020-07-10

4. Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study;EBioMedicine;2020-03

5. Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer;Current Opinion in Urology;2018-11